Hereditary Renal Cancer Syndromes: Redefining Clinical Management in the Era of Precision Medicine.
Where this comes from
- Record sourced from PubMed, PMID 42580957.
- Also identified by DOI 10.1016/j.eururo.2026.07.016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As renal tumor classification continues to evolve and new hereditary entities emerge, accurate recognition of hereditary renal neoplasms is increasingly important. Advances in precision genomics, genetic testing, and international registries will improve early detection, risk stratification, and precision management.